Efficacy and Safety of Novel Dipeptidyl-Peptidase-4 Inhibitor Evogliptin in the Management of Type 2 Diabetes Mellitus: A Meta-Analysis

AIMS: No meta-analysis is available which has summarized and holistically analyzed the efficacy and safety of evogliptin. We undertook this meta-analysis to address this gap in knowledge METHODS: Electronic databases were searched for RCTs involving diabetes patients receiving evogliptin in interven...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Deep, Bhattacharya, Saptarshi, Krishnamurthy, Aishwarya, Sharma, Lokesh Kumar, Sharma, Meha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810058/
https://www.ncbi.nlm.nih.gov/pubmed/33489850
http://dx.doi.org/10.4103/ijem.IJEM_418_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810058/
https://www.ncbi.nlm.nih.gov/pubmed/33489850
http://dx.doi.org/10.4103/ijem.IJEM_418_20

Ejemplares similares